findmyKOL

Blas Betancourt, MD

Basic profile

University of Florida

ORCIDNone on fileNPI
RegionGainesville, FL · SoutheastSpecialtyRheumatologyFocusRheumatology/Immunology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Blas Betancourt is a Rheumatology/Immunology physician affiliated with University of Florida. OpenAlex indexes 14 publications with 381 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
14publications

Distinct works indexed by OpenAlex.

381citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    36.2%
    Folate Analog Metabolic Inhibitor16.4%
    Methotrexate100%
    Part D66 patients
    TNF inhibitor6.7%
    Humira(Cf) Pen74%Enbrel Sureclick26%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    20.9%
    Corticosteroid15.3%
    Prednisone100%
    Part D75 patients
    Antidiarrheal microorganisms4.6%
    Folic Acid100%
    Part D20 patients

    + 1 more class in this area

  • Nervous system

    15%
    SNRI5.6%
    Duloxetine Hcl100%
    Part D21 patients
    Gabapentinoids3.9%
    Gabapentin56%Pregabalin44%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”